Roles of interferon-γ and interleukin-4 in murine lupus

Journal of Clinical Investigation

Volumn 99, Issue 8, 1997, Pages 1936-1946

  Peng, Stanford L ^a,b   Moslehi, Javid ^a   Craft, Joe ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

autoantibodies; autoimmunity; cytokines; lupus; rodent

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ANIMAL CELL; ARTICLE; HYPERGAMMAGLOBULINEMIA; LUPUS ERYTHEMATOSUS; LYMPHADENOPATHY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030953632     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119361     Document Type: Article

References (55)

1. Andrews, B.S., R.A. Eisenberg, A.N. Theofilopoulos, S. Izui, C.B. Wilson, P.J. McConahey, E.D. Murphy, J.B. Roths, and F.J. Dixon. 1978. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148:1198-1215.
2. Eisenberg, R.A., E.M. Tan, and F.J. Dixon. 1978. Presence of anti-Sm reactivity in autoimmune mouse strains. J. Exp. Med. 147:582-587.
3. Hewicker, M., and G. Trautwein. 1986. Glomerular lesions in MRL mice. A light and immunofluorescence microscopic study. Zentralb. Veterinarmed. Reihe B. 33:727-739.
4. Jonsson, R., A. Tarkowski, K. Backman, R. Holmdahl, and L. Klareskog. 1987. Sialadenitis in the MRL-1 mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology. 60:611-616.
5. Watanabe-Fukunaga, R., C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond.). 356:314-317.
6. Adachi, M., F.R. Watanabe, and S. Nagata. 1993. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA. 90:1756-1760.
7. Chu, J.L., J. Drappa, A. Parnassa, and K.B. Elkon. 1993. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon. ETn. J. Exp. Med. 178:723-730.
8. Kobayashi, S., T. Hirano, M. Kakinuma, and T. Uede. 1993. Transcriptional repression and differential splicing of Fas mRNA by early transposon (ETn) insertion in autoimmune lpr mice. Biochem. Biophys. Res. Commun. 191:617-624.
9. Wu, J., T. Zhou, J. He, and J.D. Mountz. 1993. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178:461-468.
10. Singer, G.G., and A.K. Abbas. 1994. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity. 1:365-371.
11. Fisher, G.H., F.J. Rosenberg, S.E. Straus, J.K. Dale, L.A. Middleton, A.Y. Lin, W. Strober, M.J. Lenardo, and J.M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 81:935-946.
12. Renno, T., M. Hahne, J. Tschopp, and H.R. MacDonald. 1996. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J. Exp. Med. 183:431-437.
13. Van Parijs, L., A. Ibraghimov, and A.K. Abbas. 1996. The roles of costimulation and fas in T cell apoptosis and peripheral tolerance. Immunity. 4: 321-328.
14. Morse, H.C., III, W.F. Davidson, R.A. Yetter, E.D. Murphy, J.B. Roths, and R.L. Coffman. 1982. Abnormalities induced by the mutant gene lpr: expansion of a unique lymphocyte subset. J. Immunol. 129:2612-2615.
15. Santoro, T.J., J.P. Portanova, and B.L. Kotzin. 1988. The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J. Exp. Med. 167:1713-1718.
16. Jevnikar, A.M., M.J. Grusby, and L.H. Glimcher. 1994. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J. Exp. Med. 179:1137-1143.
17. Koh, D.-R., A. Ho, A. Rahemutulla, W.-P. Fung-Leung, H. Griesser, and T.-W. Mak. 1995. Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur. J. Immunol. 25:2558-2562.
18. Peng, S.L., M.P. Madaio, D.P.M. Hughes, I.N. Crispe, M.J. Owen, L. Wen, A.C. Hayday, and J. Craft. 1996. Murine lupus in the absence of αβ T cells. J. Immunol. 156:4041-4049.
19. 1 lupus-like nephritis with monoclonal antibody to γ interferon. J. Exp. Med. 166:798-803.
20. Ozmen, L., D. Roman, M. Fountoulakis, G. Schmid, B. Ryffel, and G. Garotta. 1995. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-γ receptor inhibits the onset of glomerulonephritis. Eur. J. Immunol. 25:6-12.
21. 1 mice. J. Exp. Med. 179:305-310.
22. Umland, S., R. Lee, M. Howard, and C. Martens. 1989. Expression of lymphokine genes in splenic lymphocytes of autoimmune mice. Mol. Immunol. 26:649-656.
23. Prud'homme, G.J., D.H. Kono, and A.N. Theofilopoulos. 1995. Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1β, interleukin-10 and interferon-γ mRNA in the lymph nodes of lupus-prone mice. Mol. Immunol. 32:495-503.
24. Takahashi, S., L. Fossati, M. Iwamoto, R. Merino, R. Motta, T. Kobayakawa, and S. Izui. 1996. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J. Clin. Invest. 97:1597-1604.
25. Huang, F.-P., G.-J. Feng, G. Lindop, D.I. Stott, and F.Y. Liew. 1996. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. J. Exp. Med. 183:1447-1459.
26. Schorlemmer, H.U., G. Dickneite, E.J. Kanzy, and K.H. Enssle. 1995. Modulation of the immunoglobulin dysregulation in GvH- and SLE-like diseases by the murine IL-4 receptor (IL-4-R). Inflamm. Res. 44:S194-S196.
27. Tsai, C.Y., T.H. Wu, S.F. Huang, K.H. Sun, S.C. Hsieh, S.H. Han, H.S. Yu, and C.L. Yu. 1995. Abnormal splenic and thymic IL-4 and TNF-α expression in MRL-lpr/lpr mice. Scand. J. Immunol. 41:157-163.
28. Nicoletti, F., P. Meroni, R. Di Marco, W. Barcellini, M.O. Borghi, M. Gariglio, A. Mattina, S. Grasso, and S. Landolfo. 1992. In vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouse. Immunopharmacology. 24:11-16.
29. Dalton, D.K., S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley, and T.A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science (Wash. DC). 259:1739-1742.
30. Kühn, R., K. Rajewsky, and W. Müller. 1991. Generation and analysis of interleukin-4 deficient mice. Science (Wash. DC). 254:707-710.
31. Vlahakos, D.V., M.H. Foster, S. Adams, M. Katz, A.A. Ucci, K.J. Barrett, S.K. Datta, and M.P. Madaio. 1992. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int. 41:1690-1700.
32. Vlahakos, D., M.H. Foster, A.A. Ucci, K.J. Barrett, S.K. Dalla, and M.P. Madaio. 1992. Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J. Am. Soc. Nephrol. 2:1345-1354.
33. Eisenberg, R.A., J.B. Winfield, and P.L. Cohen. 1982. Subclass restriction of anti-Sm antibodies in MRL mice. J. Immunol. 129:2146-2149.
34. Prud'homme, G.J., R.S. Balderas, F.J. Dixon, and A.N. Theofilopoulos. 1983. B cell dependence on and response to accessory signals in murine lupus strains. J. Exp. Med. 157:1815-1827.
35. Steinberg, E.B., T.J. Santoro, T.M. Chused, P.A. Smathers, and A.D. Steinberg. 1983. Studies of congenic MRL-lpr/lpr.xid mice. J. Immunol. 131: 2789-2795.
36. Burlingame, R.W., R.L. Rubin, R.S. Balderas, and A.N. Theofilopoulos. 1993. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J. Clin. Invest. 91:1687-1696.
37. Klinman, D.M., and A.D. Steinberg. 1995. Inquiry into murine and human lupus. Immunol. Rev. 144:157-193.
38. Eisenberg, R.A., S.Y. Craven, C.L. Fisher, S.C. Morris, R. Rapoport, D.S. Pisetsky, and P.L. Cohen. 1989. The genetics of autoantibody production in MRL/lpr lupus mice. Clin. Exp. Rheum. 7:S35-S40.
39. Nemazee, D., C. Guiet, K. Buerki, and A. Marshak-Rothstein. 1991. B lymphocytes from the autoimmune-prone mouse strain MLR/lpr manifest an intrinsic defect in tetraparental MRL/lpr in equilibrium DBA/2 chimeras. J. Immunol. 147:2536-2539.
40. Shlomchik, M.J., M.P. Madaio, D. Ni, M. Trounstein, and D. Huszar. 1994. The role of B cells in lpr/lpr-induced autoimmunity. J. Exp. Med. 180: 1295-1306.
41. Peng, S.L., M.P. Madaio, A.C. Hayday, and J. Craft. 1996. Propagation and regulation of systemic autoimmunity by γδ T cells. J. Immunol. 157:5689-5698.
42. Eisenberg, R.A., S.Y. Craven, R.W. Warren, and P.L. Cohen. 1987. Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. J. Clin. Invest. 80:691-697.
43. Abed, N.S., J.H. Chace, and J.S. Cowdery. 1994. T cell-independent and T cell-dependent B cell activation increases IFN-γR expression and renders B cells sensitive to IFN-γ-mediated inhibition. J. Immunol. 153:3369-3377.
44. Perkins, D.L., R.M. Glaser, C.A. Mahon, J. Michaelson, and A. Marshak-Rothstein. 1990. Evidence for an intrinsic B cell defect in lpr/lpr mice apparent in neonatal chimeras. J. Immunol. 145:549-555.
45. Sobel, E.S., T. Katagiri, K. Katagiri, S.C. Morris, P.L. Cohen, and R.A. Eisenberg. 1991. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J. Exp. Med. 173:1441-1449.
46. Katagiri, T., P.L. Cohen, and R.A. Eisenberg. 1988. The lpr gene causes an intrinsic T cell abnormality that is required for hyperproliferation. J. Exp. Med. 167:741-751.
47. Sobel, E.S., P.L. Cohen, and R.A. Eisenberg. 1993. lpr T cells are necessary for autoantibody production in lpr mice. J. Immunol. 150:4160-4167.
48. Issekutz, T.B., J.M. Stoltz, and P. van der Meide. 1988. The recruitment of lymphocytes into the skin by T cell lymphokines: the role of γ-interferon. Clin. Exp. Immunol. 73:70-75.
49. Fong, T.A., and T.R. Mosmann. 1989. The role of IFN-γ in delayed-type hypersensitivity mediated by Th1 clones. J. Immunol. 143:2887-2893.
50. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R.M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-γ receptor. Science (Wash. DC). 259:1742-1745.
51. Miletic, V.D., and M.M. Frank. 1995. Complement-immunoglobulin interactions. Curr. Opin. Immunol. 7:41-47.
52. Howard, M.C., A. Miyajima, and R. Coffman. 1993. T-cell-derived cytokines and their receptors. In Fundamental Immunology. W.E. Paul, editor. Raven Press, New York. 763-800.
53. Cohen, P.L., and R.A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243-269.
54. Izui, S., V.E. Kelley, K. Masuda, H. Yoshida, J.B. Roths, and E.D. Murphy. 1984. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 133:227-233.
55. Lo, D. 1996. Animal models of human disease. Transgenic and knockout models of autoimmunity: building a better disease? Clin. Immunol. Immunopathol. 79:96-104.